Skip to main content

Advertisement

SpringerLink
Log in

Neurology of Nutritional Deficiencies

  • Neurology of Systemic Diseases (J Biller, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The goal of this chapter is to educate clinicians on the neurologic manifestations of certain nutritional deficiencies in order to promptly identify and appropriately treat these patients.

Recent Findings

Many vitamin and nutritional deficiencies have been described dating back to the early days of neurology and medicine. Some are very rare and thus, there are no randomized controlled studies to assess supplementation or dosage; however, there are reviews of case reports that can assist clinicians in choosing treatments.

Summary

While endemic vitamin and nutritional deficiencies may be rarely encountered in many countries, vulnerable populations continue to be at risk for developing neurologic complications. These populations include those with diseases causing malabsorption, the elderly, chronic alcohol users, as well as pregnant mothers with hyperemesis gravidarum to name a few. It is important to recognize syndromes associated with these nutritional deficiencies, as prompt identification and treatment may prevent permanent neurologic damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • The state of food security and nutrition in the world. Rome: Food and Agriculture Organization of the United Nations; 2019. This study reports on the current state of food insecurity and nutritional deficiencies across the world today.

  2. Dietary Reference Intakes for thiamine, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: Institute of Medicine; 1998.

  3. Said H. Thiamine. In: Coates PM, Betz JM, Blackman MR, Cragg GM, Levine M, Moss J, et al., editors. Encyclopedia of dietary supplements. 2nd ed. Informa Healthcare: London and New York; 2010. p. 748–53.

  4. Osiezagha K, Ali S, Freeman C, Barker NC, Jabeen S, Maitra S, et al. Thiamine deficiency and delirium. Innov Clin Neurosci. 2013;10(4):26–32.

    PubMed  PubMed Central  Google Scholar 

  5. Thomson AD, Marshall EJ. The natural history and pathophysiology of Wernicke’s encephalopathy and Korsakoff’s psychosis. Alcohol Alcoholism (Oxford, Oxfordshire). 2006;41(2):151–8.

    Article  CAS  Google Scholar 

  6. Wiley KD, Gupta M. Vitamin B1 Thiamine Deficiency (Beriberi). StatPearls 2019.

  7. Galvin R, Brathen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010;17(12):1408–18. https://doi.org/10.1111/j.1468-1331.2010.03153.x.

    Article  PubMed  CAS  Google Scholar 

  8. • Gasperi V, Sibilano M, Savini I, Catani MV. Niacin in the central nervous system: an update of biological aspects and clinical applications. Int J Mol Sci. 2019;20(4). https://doi.org/10.3390/ijms20040974 This is a current review of the role of niacin in the central nervous system.

    Article  CAS  Google Scholar 

  9. Hegyi J, Schwartz RA, Hegyi V. Pellagra: dermatitis, dementia, and diarrhea. Int J Dermatol. 2004;43(1):1–5.

    Article  Google Scholar 

  10. Pellagra and its prevention and control in major emergencies. World Health Organization, United Nations High Commissions for Refugees 2000.

  11. • Parra M, Stahl S, Hellmann H. Vitamin B(6) and its role in cell metabolism and physiology. Cells. 2018;7(7). https://doi.org/10.3390/cells7070084 This is a current review on vitamin B6 metabolism.

    Article  CAS  Google Scholar 

  12. Larsson SC, Orsini N, Wolk A. Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA. 2010;303(11):1077–83. https://doi.org/10.1001/jama.2010.263.

    Article  PubMed  CAS  Google Scholar 

  13. Jia K, Wang R, Tian J. Vitamin B6 intake and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Nutr Cancer. 2017;69(5):723–31. https://doi.org/10.1080/01635581.2017.1324633.

    Article  PubMed  CAS  Google Scholar 

  14. Ebbing M, Bonaa KH, Arnesen E, Ueland PM, Nordrehaug JE, Rasmussen K, et al. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. J Intern Med. 2010;268(4):367–82. https://doi.org/10.1111/j.1365-2796.2010.02259.x.

    Article  PubMed  CAS  Google Scholar 

  15. Pena IA, MacKenzie A, Van Karnebeek CDM. Current knowledge for pyridoxine-dependent epilepsy: a 2016 update. Expert Rev Endocrinol Metab. 2017;12(1):5–20. https://doi.org/10.1080/17446651.2017.1273107.

    Article  PubMed  CAS  Google Scholar 

  16. Scott K, Zeris S, Kothari MJ. Elevated B6 levels and peripheral neuropathies. Electromyogr Clin Neurophysiol. 2008;48(5):219–23.

    PubMed  CAS  Google Scholar 

  17. Vrolijk MF, Opperhuizen A, Jansen E, Hageman GJ, Bast A, Haenen G. The vitamin B6 paradox: supplementation with high concentrations of pyridoxine leads to decreased vitamin B6 function. Toxicol in Vitro. 2017;44:206–12. https://doi.org/10.1016/j.tiv.2017.07.009.

    Article  PubMed  CAS  Google Scholar 

  18. Rasul CH, Das SC. Vitamin B6 supplementation with isoniazid therapy. Trop Dr. 2000;30(1):55–6. https://doi.org/10.1177/004947550003000136.

    Article  CAS  Google Scholar 

  19. Dalton K, Dalton MJ. Characteristics of pyridoxine overdose neuropathy syndrome. Acta Neurol Scand. 1987;76(1):8–11. https://doi.org/10.1111/j.1600-0404.1987.tb03536.x.

    Article  PubMed  CAS  Google Scholar 

  20. Khan KM, Jialal I. Folic acid (folate) deficiency. StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2019.

    Google Scholar 

  21. Blom HJ, Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J Inherit Metab Dis. 2011;34(1):75–81. https://doi.org/10.1007/s10545-010-9177-4.

    Article  PubMed  CAS  Google Scholar 

  22. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006;5(11):949–60.

    Article  CAS  Google Scholar 

  23. Devalia V, Hamilton MS, Molloy AM. British Committee for Standards in H. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496–513. https://doi.org/10.1111/bjh.12959.

    Article  PubMed  CAS  Google Scholar 

  24. Kumar N. Neurologic aspects of cobalamin (B12) deficiency. Handb Clin Neurol. 2014;120:915–26. https://doi.org/10.1016/B978-0-7020-4087-0.00060-7.

    Article  PubMed  Google Scholar 

  25. Clarke R, Birks J, Nexo E, Ueland PM, Schneede J, Scott J, et al. Low vitamin B-12 status and risk of cognitive decline in older adults. Am J Clin Nutr. 2007;86(5):1384–91.

    Article  CAS  Google Scholar 

  26. Andres E, Federici L, Affenberger S, Vidal-Alaball J, Loukili NH, Zimmer J, et al. B12 deficiency: a look beyond pernicious anemia. J Fam Pract. 2007;56(7):537–42.

    PubMed  Google Scholar 

  27. Zittoun J, Zittoun R. Modern clinical testing strategies in cobalamin and folate deficiency. Semin Hematol. 1999;36(1):35–46.

    PubMed  CAS  Google Scholar 

  28. Klee GG. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B(12) and folate. Clin Chem. 2000;46(8 Pt 2):1277–83.

    PubMed  CAS  Google Scholar 

  29. Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood. 2008;112(6):2214–21. https://doi.org/10.1182/blood-2008-03-040253.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. •• Wang H, Li L, Qin LL, Song Y, Vidal-Alaball J, Liu TH. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018;3:CD004655. https://doi.org/10.1002/14651858.CD004655.pub3 This is a current systematic review evaluating the evidence for oral versus intramuscular vitamin B12 supplementation for deficiency.

    Article  PubMed  Google Scholar 

  31. Giustina A, Adler RA, Binkley N, Bouillon R, Ebeling PR, Lazaretti-Castro M, et al. Controversies in vitamin D: summary statement from an international conference. J Clin Endocrinol Metab. 2019;104(2):234–40. https://doi.org/10.1210/jc.2018-01414.

    Article  Google Scholar 

  32. Frey R, Brody T. Vitamin E Deficiency. American Society for Clinical Investigation; 2011.

  33. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington (DC): Institute of Medicine 2000.

  34. Manor D, Morley S. The a-Tocopherol Transfer Protein. Vitamins & Hormones. 2007;76:45-65. https://doi.org/10.1016/S0083-6729(07)76003-X.

    Chapter  Google Scholar 

  35. Ricciarelli R, Argellati F, Pronzato MA, Domenicotti C. Vitamin E and neurodegenerative diseases. Mol Asp Med. 2007;28(5):591–606. https://doi.org/10.1016/j.mam.2007.01.004.

    Article  CAS  Google Scholar 

  36. Kumar N. Nutritional Neuropathies. The Gale Encyclopedia of Neurological Disorders: E-O. 2017;25(1):900–6.

    Google Scholar 

  37. Azzi A. Molecular aspects of medicine. Mol Asp Med. 1978;61:92–103.

    Article  CAS  Google Scholar 

  38. Phillips JR, Angulo P, Petterson T, Lindor KD. Fat-soluble vitamin levels in patients with primary biliary cirrhosis. Am J Gastroenterol. 2001;96(9):2745. https://doi.org/10.1111/j.1572-0241.2001.04134.x.

    Article  PubMed  CAS  Google Scholar 

  39. Genetics Home Reference: TTPA gene. National Institutes of Health. 2019. Available from: https://ghr.nlm.nih.gov/gene/TTPA. Accessed: August 30, 2019.

  40. Musunuru K, Pirruccello JP, Do R, Peloso GM, Guiducci C, Sougnez C, et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med. 2010;363(23):2220–7. https://doi.org/10.1056/NEJMoa1002926.

    Article  CAS  Google Scholar 

  41. Peretti N, Sassolas A, Roy CC, Deslandres C, Charcosset M, Castagnetti J, et al. Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers. Orphanet J Rare Dis. 2010;5(1):24. https://doi.org/10.1186/1750-1172-5-24.

    Article  Google Scholar 

  42. Horwitt MK, Harvey CC, Dahm JCH, Searcy MT. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann N Y Acad Sci. 1972;203(1 Vitamin E and):223–36. https://doi.org/10.1111/j.1749-6632.1972.tb27878.x.

    Article  PubMed  CAS  Google Scholar 

  43. Gabsi S, Gouider-Khouja N, Belal S, Fki M, Kefi M, Turki I, et al. Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency. Eur J Neurol. 2001;8(5):477–81. https://doi.org/10.1046/j.1468-1331.2001.00273.x.

    Article  CAS  Google Scholar 

  44. Bachar M, Fatakhov E, Banerjee C, Todnem N. Rapidly resolving nonalcoholic Marchiafava-Bignami disease in the setting of malnourishment after gastric bypass surgery. J Investig Med High Impact Case Re. 2018;6:2324709618784318. https://doi.org/10.1177/2324709618784318.

    Article  Google Scholar 

  45. Bano S, Mehra S, Yadav SN, Chaudhary V. Marchiafava-Bignami disease: role of neuroimaging in the diagnosis and management of acute disease. Neurol India. 2009;57(5):649–52.

    Article  Google Scholar 

  46. Heinrich A, Runge U, Khaw AV. Clinicoradiologic subtypes of Marchiafava-Bignami disease. J Neurol. 2004;251(9):1050–9. https://doi.org/10.1007/s00415-004-0566-1.

    Article  PubMed  Google Scholar 

  47. Berek K, Wagner M, Chemelli AP, Aichner F, Benke T. Hemispheric disconnection in Marchiafava-Bignami disease: clinical, neuropsychological and MRI findings. J Neurol Sci. 1994;123(1-2):2–5. https://doi.org/10.1016/0022-510X(94)90195-3.

    Article  PubMed  CAS  Google Scholar 

  48. •• Hillbom M, Saloheimo P, Fujioka S, Wszolek ZK, Juvela S, Leone MA. Diagnosis and management of Marchiafava–Bignami disease: a review of CT/MRI confirmed cases. J Neurol Neurosurg Psychiatry. 2014;85(2):168–73. https://doi.org/10.1136/jnnp-2013-305979 This is a comprehensive review of imaging-confirmed cases of Marchiafava-Bignami disease and the management approaches taken.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology and Rehabilitation, University of Illinois at Chicago College of Medicine, 912 S Wood St, Chicago, IL, 60612, USA

    Kristin L. Miller, Gabriela Trifan & Fernando D. Testai

Authors
  1. Kristin L. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gabriela Trifan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fernando D. Testai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kristin L. Miller.

Ethics declarations

Conflict of Interest

Kristin L. Miller, Gabriela Trifan, and Fernando D. Testai each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Neurology of Systemic Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miller, K.L., Trifan, G. & Testai, F.D. Neurology of Nutritional Deficiencies. Curr Neurol Neurosci Rep 19, 101 (2019). https://doi.org/10.1007/s11910-019-1011-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11910-019-1011-2

Keywords

Search

Navigation